Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Second generation antipsychotics: similarities and differences].

Marek Jarema1, Janusz Rybakowski, Jerzy Landowski

  • 1III Kliniki Psychiatrycznej IPiN w Warszawie.

Psychiatria Polska
|April 11, 2003
PubMed
Summary

Second generation antipsychotics offer tailored treatment for psychotic disorders due to distinct pharmacological profiles and clinical effects. These differences allow personalized medication choices for individual patient needs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lithium effects on renal functioning: an expert opinion and management algorithm.

International journal of bipolar disorders·2026
Same author

Rethinking Schizophrenia: Optimizing Care Pathways in Europe from the First Episode of Psychosis to Long-Term Care.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Sixty years of neurotransmitter concepts of mood disorders.

Psychiatria polska·2026
Same author

Neurobiology of creativity: is there any association with bipolar mood disorder?

Psychiatria polska·2026
Same author

Sensory processing disorder in individuals with psychiatric diagnoses - A literature review.

Psychiatria polska·2025
Same author

Forty years of seasonal affective disorder.

Psychiatria polska·2025

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Therapeutics

Context:

  • Second-generation antipsychotics (SGAs) are widely used for treating psychotic disorders.
  • A variety of SGAs are available on the Polish market.
  • Understanding their specific properties is crucial for effective treatment.

Purpose:

  • To describe the pharmacological profiles of available second-generation antipsychotics.
  • To compare their clinical efficacy and tolerability.
  • To highlight the differences among these medications.

Summary:

  • Second-generation antipsychotics exhibit both shared characteristics and notable distinctions in their mechanisms of action.
  • Analysis reveals significant variations in pharmacological properties, clinical efficacy, and tolerability among SGAs.

Related Experiment Videos

  • These differences are key to their therapeutic value in managing psychotic disorders.

    • Impact:

    • The distinct properties of SGAs enable personalized treatment strategies for patients with psychotic disorders.
    • Tailoring antipsychotic therapy based on individual patient needs is a significant advantage of second-generation agents.
    • Recognizing these intra-class differences optimizes therapeutic outcomes and patient care.